Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Eng

Showing results (161-170 of 315) with videos related to

Pageof 32
Sort By:
Cancer|January 30, 2014
Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007Alex B Haynes, Y Nancy You, Chung-Yuan Hu, et al.
Cancers|March 13, 2025
Genomic Landscapes of Early-Onset Versus Average-Onset Colorectal Cancer PopulationsMichael H Storandt, Qian Shi, Cathy Eng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapyScott Kopetz, George J Chang, Michael J Overman, et al.
Cancers|August 12, 2023
Hepatic Metastasectomy in Squamous Cell Carcinoma of the Anal Canal: A Case Series of a Curative ApproachJane E Rogers, Amanda Sirisaengtaksin, Michael Leung, et al.
Clinical Colorectal Cancer|July 19, 2020
Bevacizumab Does Not Influence the Efficacy of Partial Splenic Embolization in the Management of Chemotherapy-Induced HypersplenismAlexandre A Jácome, Aki Ohinata, Armeen Mahvash, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neckMichael T Milano, Daniel J Haraf, Kerstin M Stenson, et al.
Gastrointestinal Cancer Research : GCR|March 6, 2009
Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancerManpreet Bedi, Prajnan Das, John M Skibber, et al.
International Journal of Radiation Oncology, Biology, Physics|August 22, 2009
Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiationPrajnan Das, Marc E Delclos, John M Skibber, et al.
Cancer|October 26, 2007
Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastasesDario Ribero, Huamin Wang, Matteo Donadon, et al.
Cancer Discovery|December 15, 2022
Racial/Ethnic and Sex Differences in Somatic Cancer Gene Mutations among Patients with Early-Onset Colorectal CancerAndreana N Holowatyj, Wanqing Wen, Timothy Gibbs, et al.
Pageof 32

Showing results (161-170 of 315) with videos related to

Sort By:
Pageof 32
Cancer|January 30, 2014
Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007Alex B Haynes, Y Nancy You, Chung-Yuan Hu, et al.
Cancers|March 13, 2025
Genomic Landscapes of Early-Onset Versus Average-Onset Colorectal Cancer PopulationsMichael H Storandt, Qian Shi, Cathy Eng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapyScott Kopetz, George J Chang, Michael J Overman, et al.
Cancers|August 12, 2023
Hepatic Metastasectomy in Squamous Cell Carcinoma of the Anal Canal: A Case Series of a Curative ApproachJane E Rogers, Amanda Sirisaengtaksin, Michael Leung, et al.
Clinical Colorectal Cancer|July 19, 2020
Bevacizumab Does Not Influence the Efficacy of Partial Splenic Embolization in the Management of Chemotherapy-Induced HypersplenismAlexandre A Jácome, Aki Ohinata, Armeen Mahvash, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neckMichael T Milano, Daniel J Haraf, Kerstin M Stenson, et al.
Gastrointestinal Cancer Research : GCR|March 6, 2009
Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancerManpreet Bedi, Prajnan Das, John M Skibber, et al.
International Journal of Radiation Oncology, Biology, Physics|August 22, 2009
Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiationPrajnan Das, Marc E Delclos, John M Skibber, et al.
Cancer|October 26, 2007
Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastasesDario Ribero, Huamin Wang, Matteo Donadon, et al.
Cancer Discovery|December 15, 2022
Racial/Ethnic and Sex Differences in Somatic Cancer Gene Mutations among Patients with Early-Onset Colorectal CancerAndreana N Holowatyj, Wanqing Wen, Timothy Gibbs, et al.
Pageof 32